Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00792246 · ClinicalTrials.gov registry record · Phase 1
Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease
A Phase 1 study, sponsored by Phillip Brian Smith.
- Completed
- Registry status
- Phase 1
- Development phase
- 5
- Enrollment target
NCT00792246: Completed Phase 1 study, sponsored by Phillip Brian Smith.
NCT00792246 is a Phase 1 study that has completed, run by Phillip Brian Smith. The registered enrollment target is 5 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00792246, a Phase 1 study, has completed, sponsored by Phillip Brian Smith.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 5 participants
- Enrollment target
Study Summary
Determine how much voriconazole is absorbed when the product is given by mouth to children with extensive graft versus host disease after a stem cell transplantation and determine the correct dosing of voriconazole in this population. Hypothesis: Children with gastrointestinal graft versus host disease will have decreased absorption of oral voriconazole and require higher doses of voriconazole in order to prevent or treat fungal infections.
Interventions
- DRUG voriconazole
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2008-12 |
| Est. Completion | 2012-07 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00792246
The ClinicalTrials.gov registry entry for NCT00792246 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phillip Brian Smith, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which voriconazole is the first listed.
NCT00792246 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00792246 about?
NCT00792246 is a clinical study titled "Voriconazole Pharmacokinetics in Children With Gastrointestinal Graft Versus Host Disease". Determine how much voriconazole is absorbed when the product is given by mouth to children with extensive graft versus host disease after a stem cell transplantation and determine the correct dosing of voriconazole in this population. Hypothesis: Children with gastrointestinal graft versus host dis...
What is the current status of trial NCT00792246?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 5 participants. The study started on 2008-12. Estimated completion is 2012-07.
What interventions are being tested in trial NCT00792246?
The interventions under investigation include: voriconazole (DRUG).
Who is sponsoring clinical trial NCT00792246?
This trial is sponsored by Phillip Brian Smith, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.